Researchers with metabolic syndrome, elevated liver enzymes, or suspected NAFLD have a metabolic profile that aligns well with the dual benefits of tirzepatide (glycemic control, appetite reduction) and levocarnitine (enhanced hepatic fat oxidation, improved insulin sensitivity at the cellular level)
These common side effects are usually temporary
Four common routes, and how each holds up as of July 2026
Parseghian CM, Parikh NU, Wu JY, Jiang ZQ, Henderson L, Tian F, Pastor B, Ychou M, Raghav K, Dasari A, Fogelman DR, Katsiampoura AD, Menter DG, Wolff RA, Eng C, Overman MJ, Thierry AR, Gallick GE, Kopetz S
Or the afternoon, depending on your routine
we frame it as a supportive tool, not a replacement for GLP-1 when that's the better fit